{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:06:29Z","timestamp":1779771989032,"version":"3.53.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012249","name":"Jiangxi University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["CXTD22003"],"award-info":[{"award-number":["CXTD22003"]}],"id":[{"id":"10.13039\/501100012249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012249","name":"Jiangxi University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["CXTD22001"],"award-info":[{"award-number":["CXTD22001"]}],"id":[{"id":"10.13039\/501100012249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["20232ACB216016"],"award-info":[{"award-number":["20232ACB216016"]}],"id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["20242BAB20458"],"award-info":[{"award-number":["20242BAB20458"]}],"id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["20232BCJ22054"],"award-info":[{"award-number":["20232BCJ22054"]}],"id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160663"],"award-info":[{"award-number":["82160663"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bmc.2025.118318","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:13:40Z","timestamp":1752642820000},"page":"118318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and antidiabetic activities of 5-methoxypyrimidine derivatives targeting GPR119 and DPP-4"],"prefix":"10.1016","volume":"129","author":[{"given":"Fukang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118318_bb0005","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1016\/j.bmc.2018.06.035","article-title":"Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes","volume":"26","author":"Fang","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118318_bb0010","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.2174\/1389557523666230302140658","article-title":"Structural insight on GPR119 agonist as potential therapy for type II diabetes: a comprehensive review","volume":"23","author":"Nema","year":"2023","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmc.2025.118318_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.bmc.2025.118318_bb0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular complications of type 2 diabetes mellitus","volume":"18","author":"Viigimaa","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.bmc.2025.118318_bb0025","article-title":"Emerging targets in type 2 diabetes and diabetic complications","volume":"8","author":"Demir","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bmc.2025.118318_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1248\/bpb.b24-00737","article-title":"Pharmacological profile of NCP-322, a novel G protein-coupled receptor 119 agonist, as an orally active therapeutic agent for type 2 diabetes mellitus","volume":"48","author":"Nakamura","year":"2025","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bmc.2025.118318_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/B978-0-12-381517-0.00016-3","article-title":"GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders","volume":"84","author":"Shah","year":"2010","journal-title":"Vitam Horm"},{"key":"10.1016\/j.bmc.2025.118318_bb0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/03007995.2024.2333440","article-title":"Diabetes: a review of its pathophysiology, and advanced methods of mitigation","volume":"40","author":"Gupta","year":"2024","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bmc.2025.118318_bb0045","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/13543776.2021.1921152","article-title":"GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present)","volume":"31","author":"Li","year":"2021","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2025.118318_bb0050","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1021\/acs.jmedchem.4c00838","article-title":"Systematic investigation of dual-target-directed ligands","volume":"67","author":"Lembo","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118318_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108075","article-title":"Multi-target directed ligands inspired natural products as an effective approach for the treatment of complex chronic health disorders","volume":"154","author":"Shaaban","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118318_bb0060","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/cells9061380","article-title":"Cancer biology and prevention in diabetes","volume":"9","author":"Srivastava","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2025.118318_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.phrs.2018.01.015","article-title":"Natural products for the treatment of type 2 diabetes mellitus: pharmacology and mechanisms","volume":"130","author":"Xu","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmc.2025.118318_bb0070","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.3390\/cells11233767","article-title":"Development of dementia in type 2 diabetes patients: mechanisms of insulin resistance and antidiabetic drug development","volume":"11","author":"Singh","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2025.118318_bb0075","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1021\/acs.jmedchem.4c02655","article-title":"Discovery of 1,4-disubstituted cyclohexene analogues as selective GPR119 agonists for the treatment of type 2 diabetes","volume":"68","author":"La","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118318_bb0080","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1038\/s41598-017-04633-5","article-title":"The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo","volume":"7","author":"Huan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2025.118318_bb0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/13543784.2024.2321271","article-title":"GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates","volume":"33","author":"Hryciw","year":"2024","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmc.2025.118318_bb0090","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc07-0228","article-title":"Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action","volume":"30","author":"Drucker","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bmc.2025.118318_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1517\/13543784.12.1.87","article-title":"Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes","volume":"12","author":"Drucker","year":"2003","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmc.2025.118318_bb0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejmech.2016.08.023","article-title":"Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents","volume":"124","author":"Li","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118318_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103390","article-title":"Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators","volume":"94","author":"Fang","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118318_bb0110","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2174\/1389557520666200228144148","article-title":"Review on chemistry, analysis and pharmacology of teneligliptin: a novel DPP-4 inhibitor","volume":"20","author":"Sharma","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmc.2025.118318_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lfs.2011.10.007","article-title":"DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes","volume":"90","author":"Kim","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2025.118318_bb0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4093\/dmj.2021.0056","article-title":"DA-1241, a novel GPR119 agonist, improves hyperglycaemia by inhibiting hepatic gluconeogenesis and enhancing insulin secretion in diabetic mice","volume":"46","author":"Kim","year":"2022","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.bmc.2025.118318_bb0125","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10517-017-3881-0","article-title":"Effect of GRP119 receptor agonist, compound MBX-2982, on activity of human glucokinase","volume":"163","author":"Spasov","year":"2017","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.bmc.2025.118318_bb0130","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s12272-017-0925-y","article-title":"YH18421, a novel GPR119 agonist exerts sustained glucose lowering and weight loss in diabetic mouse model","volume":"40","author":"Park","year":"2017","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.bmc.2025.118318_bb0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12325-018-0668-2","article-title":"Efficacy and safety of GPR119 agonist DS-8500a in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study","volume":"35","author":"Yamada","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.bmc.2025.118318_bb0140","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbrc.2017.12.004","article-title":"Co-administration of APD668, a G protein-coupled receptor 119 agonist and linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in mice fed on a high trans-fat diet","volume":"495","author":"Bahirat","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2025.118318_bb0145","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/14728222.2024.2421751","article-title":"What is holding back preclinical GPR119 agonists from their potential as the therapeutics of type 2 diabetes?","volume":"28","author":"Hu","year":"2024","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bmc.2025.118318_bb0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/14756366.2019.1681988","article-title":"Optimisation of novel 4, 8-disubstituted dihydropyrimido[5,4-b][1,4]oxazine derivatives as potent GPR 119 agonists","volume":"35","author":"Fang","year":"2020","journal-title":"J Enzyme Inhib Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:54:40Z","timestamp":1779771280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625002597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"alternative-id":["S0968089625002597"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118318","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and antidiabetic activities of 5-methoxypyrimidine derivatives targeting GPR119 and DPP-4","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118318"}}